Unique blood protein patterns in long COVID patients could reveal potential drug targets

FHS
July 7, 2023
11:45 pm

Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.

Stryker plans ‘very active’ M&A, ortho robot launches in 2H

By the numbers Q2 revenue: $5.42 billion 8.5% increase year over year Net income: $825 million 11.8% increase year over year Stryker set another record

July 31, 2024

What readers have to say about long Covid, FDA and diversity, and more

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care

June 29, 2024

APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published – Biotech Investments

EQS-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/9 Month figures APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.